| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/30/2007 | US7169799 Process for producing crystal |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169791 Inhibitors of tyrosine kinases |
| 01/30/2007 | US7169789 Quinoline derivatives and quinazoline derivatives |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169774 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy |
| 01/30/2007 | US7169762 Prepared by reacting a culture solution obtained by preliminarily culturing basidiomycetes with a reaction mixture obtained by reacting bran extracts with an enzyme; use as food, medicine and feedstuff utilizing the physiological activity of the substance; |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169754 Blood disorders; drug in aqueous solution |
| 01/30/2007 | US7169753 Such as magnesium-containing tetrahydroporphyrin for use in photodynamic therapy, tumor diagnosis, bactericides, and viricides; transesterification |
| 01/30/2007 | US7169594 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 01/30/2007 | US7169585 Papillomavirus vaccine |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | CA2284859C Nucleic acid molecule for a human skeletal muscle-specific receptor |
| 01/30/2007 | CA2260060C Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 01/30/2007 | CA2257235C Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity |
| 01/30/2007 | CA2214322C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 01/30/2007 | CA2210751C Anti-cd6 monoclonal antibodies and their uses |
| 01/30/2007 | CA2167693C Melanoma-inhibiting protein |
| 01/30/2007 | CA2107537C Inhibition of tumor cell growth by administration of b7-transfected cells |
| 01/29/2007 | CA2554737A1 Compositions and methods for treating cancer and other diseases characterized by abnormal cell proliferation |
| 01/25/2007 | WO2007012042A1 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide |
| 01/25/2007 | WO2007011811A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011809A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011760A2 Inhibitors of mitotic kinesin |
| 01/25/2007 | WO2007011721A1 Inhibitors of mitotic kinesin |
| 01/25/2007 | WO2007011693A2 Compositions of placentally-derived stem cells for the treatment of cancer |
| 01/25/2007 | WO2007011618A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010946A1 Synovial cell proliferation inhibitor |
| 01/25/2007 | WO2007010885A1 Substituted propanamide derivative and pharmaceutical composition containing the same |
| 01/25/2007 | WO2007010853A1 Method for control of electroporation apparatus |
| 01/25/2007 | WO2007010628A1 Prophylactic/therapeutic agent for cancer |
| 01/25/2007 | WO2007010547A1 A phyto-medicine and a process for the preparation thereof |
| 01/25/2007 | WO2007010394A2 Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps |
| 01/25/2007 | WO2007010307A1 Antineoplastic compounds |
| 01/25/2007 | WO2007010235A1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide |
| 01/25/2007 | WO2007010128A1 Target vector with activable imaging function |
| 01/25/2007 | WO2007010044A1 3-indolylmethylene derivatives with cytostatic action |
| 01/25/2007 | WO2007010013A2 Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases |
| 01/25/2007 | WO2007010012A2 Combination of a pyrimidylaminobenzamide and an mtor kinase inhibitor |
| 01/25/2007 | WO2007009898A1 1h-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors |
| 01/25/2007 | WO2007009819A1 Acylglycerophospholipids for treating symptoms concomitant with cancer |
| 01/25/2007 | WO2007009773A1 Pyrazolo[1.5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors |
| 01/25/2007 | WO2007009734A2 Combination preparation, particularly for treating prostate cancer |
| 01/25/2007 | WO2007009724A2 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009723A2 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009722A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009721A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009720A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009705A1 (rac)-n-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydr0-1h-pyrazole-3-carboxamide hydrates |
| 01/25/2007 | WO2007009690A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009689A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009539A2 Use of inhibitors of histone deacetylases in combination with nsaid for the therapy of cancer and/or inflammatory diseases |
| 01/25/2007 | WO2007009395A1 Schisandrin b preparation |
| 01/25/2007 | WO2007009383A1 A rectum suppository of protein and its preparation method and the use |
| 01/25/2007 | WO2007009355A1 Paclitaxel injection and preparation method thereof |
| 01/25/2007 | WO2007009317A2 Peptide drug for inhibiting solid tumour and cancer cell of leukaemia |
| 01/25/2007 | WO2007009245A1 Stabilized chlorite solutions in combination with fluoropyrimidines for cancer treatment. |
| 01/25/2007 | WO2007009229A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 01/25/2007 | WO2007009191A1 Method for treating cancer |
| 01/25/2007 | WO2006124863A3 Pyrrolopyridine derivatives as protein kinase inhibitors |
| 01/25/2007 | WO2006122408A9 Bir domain binding compounds |
| 01/25/2007 | WO2006117400A3 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors |
| 01/25/2007 | WO2006089298A3 Pyrimidine-fused diazepine derivatives and indole-fused pteridines |
| 01/25/2007 | WO2006084030A3 Small-molecule hsp90 inhibitors |
| 01/25/2007 | WO2006071990A3 Methods to bypass cd+4 cells in the induction of an immune response |
| 01/25/2007 | WO2006039238A3 Irta2 antibodies and methods of use |
| 01/25/2007 | WO2005118777A8 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 01/25/2007 | WO2004108065A3 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies |
| 01/25/2007 | US20070021917 3-structure of a whole integrin $g(a) v$g(b) extracellular region and uses therefor |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021492 Sulfamatet benzothiophene derivatives as steroid sulfatase inhibitors |
| 01/25/2007 | US20070021481 Anti-androgenic N-[ omega -[3-[4-cyano-3-(trifluoromethyl)-phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]alkyl]-substituted pyrrolidines; treatment of prostate cancer, benign prostate hyperplasia, androgenetic alopecia, hirsutism or acne |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021432 Treatment of mesothelioma |
| 01/25/2007 | US20070021427 Novel tricyclic derivatives and their use |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021419 2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 01/25/2007 | US20070021418 Method of inhibiting production of osteopontin |
| 01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
| 01/25/2007 | US20070021388 trans-stereochemistry to improve half life, oral bioavailability and activity; liver disorderslike liver cancer, liver infections, fibrosis, obesity; trans-4-(3-chlorophenyl)-2-(4-nitrophenoxy)-2-oxo-1,3,2-dioxaphosphorinane |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021360 Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase |
| 01/25/2007 | US20070021350 Conjugates useful in the treatment of prostate cancer |
| 01/25/2007 | US20070021334 Class III slrp agonists for the reduction of blood vessel formation |
| 01/25/2007 | US20070021321 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent |
| 01/25/2007 | US20070020694 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 01/25/2007 | US20070020348 Composition for treating hepatitis c |
| 01/25/2007 | US20070020337 Paclitaxel-based antitumor formulation |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |